Boekstegers P, Hausleiter J, Baldus S, von Bardeleben R S, Beucher H, Butter C, Franzen O, Hoffmann R, Ince H, Kuck K H, Rudolph V, Schäfer U, Schillinger W, Wunderlich N
Clin Res Cardiol. 2014 Feb;103(2):85-96. doi: 10.1007/s00392-013-0614-x.
The interventional treatment of mitral valve regurgitation by the MitraClip procedure has grown rapidly in Germany and Europe during the past years. The MitraClip procedure has the potential to treat high-risk patients with secondary mitral valve regurgitation and poor left ventricular function. Furthermore, patients with primary mitral valve regurgitation may be treated successfully by the MitraClip procedure in case of high surgical risk or in very old patients. At the same time it has been emphasised that the MitraClip interventional treatment is still at an early stage of clinical development. The largest clinical experience with the MitraClip procedure so far is probably present in some German cardiovascular centers, which here summarise their recommendations on the current indications and procedural steps of the MitraClip treatment. These recommendations of the AGIK and ALKK may present a basis for future development.
在过去几年中，德国和欧洲通过MitraClip手术对二尖瓣反流进行的介入治疗发展迅速。MitraClip手术有潜力治疗患有继发性二尖瓣反流且左心室功能不佳的高危患者。此外，对于手术风险高或年龄非常大的原发性二尖瓣反流患者，MitraClip手术也可能成功治疗。同时需要强调的是，MitraClip介入治疗仍处于临床发展的早期阶段。目前，德国一些心血管中心可能拥有关于MitraClip手术的最大临床经验，这些中心在此总结了他们对MitraClip治疗当前适应症和手术步骤的建议。AGIK和ALKK的这些建议可能为未来的发展奠定基础。
